Back to search
FDAFDA · Food and drugs·Recall number D-0165-2026

DermaSarra, Camphor 0.5%, External Analgesic, 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08

Published November 26, 2025 · Recall initiated: August 27, 2025

Summary

FDA records drug Class II recall D-0165-2026, published November 26, 2025 and initiated August 27, 2025. Recalling firm: DermaRite Industries, LLC; Status: Ongoing; Reported quantity: 2,389 bottles; Lot: All lots on or before expiry date 08/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DermaRite Industries, LLC
Distributor
Nationwide in the USA
Lot
All lots on or before expiry date 08/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DermaSarra, Camphor 0.5%, External Analgesic, 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08 recalled?

Yes. FDA published recall D-0165-2026 on November 26, 2025. Reported hazard: CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit